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Key summary points
Aim To develop an easy-to-use delirium risk assessment score (DRAS) to establish if a patient admitted to a hospital is at 
risk of getting delirium.
Findings Our delirium risk assessment score (DRAS) based on the admission interview showed that risk of delirium based 
on predisposing risk factors can be assessed easily without elaborate cognitive testing and/or laboratory results and therefore 
less stressful for the patient. The DRASs as good as or somewhat better than other risk assessment scores are not developed 
for one specific population.
Message Because there is still a lack of knowledge, competence and awareness regarding delirium, understanding delirium 
risk factors helps clinicians, patients and caregivers in targeting non-pharmacological and pharmacological interventions 
aimed at lessening its burden.
Abstract
Purpose Development and validation of a delirium risk assessment score. Predisposing risk factors for delirium were used, 
which are easily assessed at hospital admission without additional clinical or laboratory testing.
Methods A systematic literature search identified ten risk factors: acute admission, alcohol use > 4 units/day, cognitive 
impairment, ADL impairment, age > 75 years, earlier delirium, hearing/vision problems, number of medication ≥ 5, number 
of morbidities > 2 and male. The DRAS was developed in a mixed patient population (N = 842) by the use of univariate and 
multivariate analyses and -2 log-likelihood calculation to weigh the risk factors. Based on the sensitivity and specificity, a 
cutoff score was calculated. The validation was performed in 3 cohorts (N = 408, N = 186, N = 365). In cohort 3, the DRAS 
was compared (AUC, sensitivity and specificity) to 3 instruments (Inouye, Kalisvaart, VMS rules).
Results The delirium incidence was 31.8%, 20.3%, 15.6% and 15.1%. All risk factors were independently predictive for 
delirium, except male. The multivariate analyses excluded morbidities. The final DRAS consists of 8 items; acute admission, 
cognitive impairment, alcohol use (3 points), ADLimpairment/mobilityproblems (2 points), higher age, earlier delirium, 
hearing/vision problems, and medication (1 point). The total score is 15 points and at a cut-of score of 5 or higher the patient 
is at risk of developing a delirium. The cutoff was at 5 or more points, AUC: 0.76 (95% CI 0.72–0.79), sensitivity 0.77, speci-
ficity 0.60. Validation cohorts AUC was 0.75 (95% CI 0.96–0.81), 0.76 (95% CI 0.70–0.83) and 0.78 (95% CI 0.70–0.87), 
sensitivity 0.71, 0.67 and 0.89 and specificity 0.70, 0.72 and 0.60. The comparison revealed the highest AUC for the DRAS.
Conclusion Based on an admission interview, the delirium risk can be easily evaluated using the DRAS shortlist score of 
predisposing risk factors for delirium in older inpatients.
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Introduction
Delirium is a serious complication in older inpatients [1–3]. 
It is multifactorial determined and based on a combination of 
predisposing and precipitating risk factors. Incidence rates 
for delirium vary among various hospital patient populations 
ranging from 5 to 87% [3]. Patients with delirium often have 
high morbidity and mortality, prolonged hospital length of 
stay and high rates of institutionalization and dementia fol-
lowing discharge [2–7].
The current guidelines and trials suggest that about one-
third of all delirium episodes could have been prevented by 
assessing systematic programs, and that delirium preven-
tion would be a cost-effective strategy [8, 9]. Recent studies 
also showed that there is a lack of knowledge, competence, 
awareness regarding delirium, prevention of delirium and the 
use of screening tools for detection and severity of delirium 
among clinicians [10–12]. There is also a relation between 
frail older people and delirium due to the fact that frail older 
people have also more predisposing risk factors for delirium 
than those who are not frail [13, 14]. Therefore, it seems pru-
dent to screen hospitalized patients for their risk of delirium 
to create awareness that a patient is at risk and because clini-
cians can develop plans to mitigate the risk. Understanding 
delirium risk factors may even help clinicians, patients and 
caregivers in targeting non-pharmacological and pharmaco-
logical interventions aimed at lessening its burden.
Identification of modifiable predisposing and precipitat-
ing risk factors for delirium is a prerequisite for an individual 
approach for the prevention of delirium. The predisposing 
delirium risk factors are already identifiable on admission, 
and the amount of predisposing risk factors present denotes 
the older patient’s vulnerability for delirium during admis-
sion [6]. Several screening instruments have been suggested 
to detect patients at risk of delirium. Lindroth (2018) found 
23 prediction screening instruments [15]. The instruments 
in this review showed that they were often based on com-
plex methods such as scale administration (MMSE, Barthel, 
KATZ, GDS) and interpretation of laboratory measurements 
which need time and knowledge to perform, and they were 
developed for specific patient populations and are not vali-
dated.[9, 16–24]
The aim of this study was to evaluate whether patient 
characteristics of older patients admitted to a hospital, which 
can be assessed quickly and easily on admission based on 
an admission interview and without additional clinical or 
laboratory testing, may serve to stratify older inpatients with 
respect of their delirium risk.
Methods
Participants and setting
In this study four different patient cohorts were used, a 
development cohort and three validation cohorts.
The development cohort, consisting of a population of 
842 older patients (mixed surgical/non-surgical) who were 
admitted to a teaching hospital in the Spaarne Gasthuis in 
Haarlem from 2009 till 2011, was used to develop the pre-
diction screening instrument delirium risk assessment score 
(DRAS). The DRAS was validated using three cohorts. Vali-
dation cohort 1 is a cohort of 408 orthopedic patients admit-
ted to the same hospital in 2010 till 2012. Validation cohort 
2 is a cohort of 186 surgical patients admitted in 2016 to the 
Spaarne Gasthuis hospital in Haarlem. Validation cohort 3 is 
a cohort of 365 of 603 orthopedic patients from the Halop-
eridol study population that took place in 2000 to 2002 in the 
Medisch Centrum Alkmaar hospital in Alkmaar, the Neth-
erlands [25]. The validation was done retrospective because 
data were already available. The haloperidol study included 
in total 603 patients, but due to missing data at admission 
238 out of 603 patients had to be excluded from analysis of 
the third validation cohort.
Inclusion and exclusion criteria were the same in all 
populations. Included were all people with the age 65 or 
over, no delirium on admission (CAM and confirmation by a 
geriatrician) and hospital stay ≥ 72 h. Consent was obtained 
by patient or relative (if the patient was not able to give 
consent).
Risk factors and assessment on admission
The potential predisposing risk factors for delirium were 
selected after a systematic review of the literature published 
from 1990 to 2008 and using reviews published from 2008 to 
2011 [25–32]. Risk factors which are independent associated 
with delirium found in the literature were: older age, male 
gender, sensory impairment (visual and hearing impair-
ment), cognitive comorbidity (dementia, cognitive impair-
ment, depression), acute admission, functional impairments 
and disability (immobility, functional dependence, fracture 
on admission), malnutrition (alcoholism, dehydration), poly-
pharmacy and medical comorbidity (high burden of illness). 
The predisposing risk factors that were selected were based 
on their characteristics to be easy to assess without addi-
tional clinical or laboratory test results. This resulted in the 
following potential predisposing risk factors for delirium: 
acute vs planned admission, alcohol use ≥ four units per day 
vs < four units, cognitive impairment yes vs no, hearing/
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vision problems yes vs no, help needed for activities of 
daily living (ADL) yes vs no, age ≥ 75 vs < 75 years, previ-
ous delirium yes vs no, number of medication ≥ 5 vs < 5, 
number of morbidities > two vs ≤ two and male yes vs no. 
Cognition was scored as diagnosis of dementia, or if patient 
or their relative mentioned any cognition problems. The 
patient ability to perform activities of daily living (ADL) 
was scored if patients and/or relatives mentioned any help 
for ADL at home and/or needed devices as support for their 
mobility. Patients and/or their relatives were asked whether 
they have experienced delirium, confusion or disorientation 
in a previous admission. Hearing and vision problems were 
scored if patient was not able to solve hearing and/or vision 
problems by using glasses or a hearing aid.
In the validation cohort 3 data were used out of an exist-
ing database, and the risk factors for the DRAS were estab-
lished as follows: For cognition, a Mini-Mental State Exami-
nation (MMSE) score of ≤ 24 points was used [33], and for 
vision problems, the Snellen vision test (> 20/70) was used 
[34]. Other risk factors were measured in the same way as 
in the development cohort.
Test characteristics of the DRAS were compared with the 
Inouye risk score and the Kalisvaart risk screening instru-
ment and the Dutch Safety Monitoring (Veiligheids Man-
agement System (VMS)) screening instrument [9, 21, 35]. 
The variables used in these tools are already available in the 
data. The Inouye model is a well-known risk model cited 
in more than 800 articles and often used in research. The 
Dutch hospitals use the VMS in daily practice to screen for 
patients at risk.
For the Inouye risk screening instrument, the following 
4 risk factors were scored: cognitive impairment (MMSE)30 
score of ≤ 24 points on a scale of 0 to 30 points, visual 
impairment, defined as binocular near vision, Snellen vision 
test worse than 20/70 after correction vision [36], index 
of dehydration (ratio of blood urea nitrogen to creatinine 
of ≥ 18) and severity of illness, measured by the Apache II 
(Acute Physiology Age and Chronicle Health Examination), 
score of ≥ 16 on a scale of 0 to 70 [34] and for the Kalis-
vaart risk screening instrument the factors: age, cognition 
(MMSE ≤ 24 points) and acute admission. The VMS screen-
ing instrument for delirium uses 3 questions: ‘Do you expe-
rience cognitive problems?’, ‘Have you needed ADL support 
within 24 h before admission?’, ‘Did you had a delirium dur-
ing another admission?’. The VMS was not developed and 
validated in a scientific study but already used in the Dutch 
hospitals. That is why it is used to compare the DRAS with 
the VMS in this study.
Delirium Assessment
In the development cohort and the validation cohorts a 
brief delirium assessment (< 15 min) was performed daily 
from day one till three days after admission or operation 
by trained interviewers which could be a research nurse or 
a doctor not involved in the patient’s treatment to screen 
for delirium symptoms by the use of confusion assessment 
method (CAM) [37] assessed delirium. If the patient scored 
positive on the CAM, a geriatrician confirmed the diagno-
sis based on DSM-IV and DSM-V. The daily assessment 
was augmented with medical and nursing record review 
for evidence of intervening delirium features (e.g., acute 
onset, inattention, disorganized thinking, altered level of 
consciousness, disorientation, memory impairment, per-
ceptual disturbances, psychomotor agitation or retardation 
and altered sleep–wake cycle) and medical treatment for 
delirium.
Statistics
Statistical calculations were performed using SPSS for Win-
dows, version 18.0 (SPSS, Chicago Inc. Chicago, IL). Each 
potential risk factor for delirium was tested with the primary 
outcome measurements using Chi-square tests for nominal 
variables, the Mann–Whitney U test for ordinal variables 
and the unpaired 2-tailed t test for continuous variables. A 
logistic univariate regression analyses were performed to 
establish if the predisposing risk factor was related to the 
development of delirium. All used risk factors with a value 
of P < 0.2 were included in the multivariate stepwise logis-
tic regression analysis. To facilitate the use of the DRAS, 
we developed weights for all risk factors based on the odds 
ratios (OR) of the estimated risk factor.
The performance of the risk model (DRAS) was meas-
ured using receiver operating characteristic (ROC) analysis. 
For the best performance of the DRAS, a cutoff point was 
calculated using the best score on sensitivity and specificity. 
Furthermore, for the comparison part of this study the sensi-
tivity and specificity were calculated of the other screening 
instruments used.
The studies were done in accordance with the Declara-
tion of Helsinki and the guidelines on good clinical practice. 
Approval was obtained from the AdviesCommissie Locale 
Uitvoerbaarheid (ACLU), the local committee of the METC 
of our hospital. All patients and relatives were informed ver-
bally. Patients and/or relatives gave their verbal consent for 
obtaining the data.
The data that support the findings of this study are avail-
able on request from the corresponding author. The data are 
not publicly available due to privacy or ethical restrictions.
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Results
The delirium incidence was 268/842 (31.8%) in the develop-
ment cohort, 83/408 (20.3%) in validation cohort 1, 28/186 
(15.1%) in validation cohort 2 and 57/365 (15.6%) in valida-
tion cohort 3.
Demographic characteristics of the participants in the 
cohorts are described in Table 1.
Nine out of ten risk factors for delirium described in the 
literature were related to the development of delirium in 
the development cohort. Male gender was not significantly 
associated with delirium (P = 0.051). In the multivariate 
stepwise logistic regression analysis, comorbidity was the 
only risk factor which lost significance predicting delirium 
(Table 2). Of the ten used variables eight remain in the final 
model. The OR of the delirium risk factors was calculated to 
attribute weight to them. After weighing the risk factors, the 
final DRAS consisted of three points for acute admission, 
alcohol use and cognition impairment, two points to ADL 
impairment and one point to the other risk factors. The final 
DRAS has a ROC curve of AUC 0.76 (95% CI 0.72–0.79). 
The cutoff point was calculated using the best score on sen-
sitivity and specificity and showed the best prediction of 
risk of delirium at a score of ≥ 5. In the development cohort 
211 patients had five DRAS points or more accounting for 
79% of the delirium incidence. Furthermore, the higher the 
Table 1  Patient characteristics of the development and three validation cohorts stratified by delirium
Results prescribed as N, (%) unless otherwise stated
Development Cohort,  
N = 842
Validation cohort 1, 
N = 408




No delirium Delirium No delirium Delirium No delirium Delirium No delirium Delirium
N = 574 N = 268 N = 325 N = 83 N = 158 N = 28 N = 308 N = 57
Age
 Mean (SD) 79.3 (6.19) 81.8 (6.45) 78.5 (5.82) 82.7 (5.87) 79.7 (7.3) 80.6 (6.45) 78.3 (5.72) 82.1 (6.11)
 75 years or older 428 (64.8) 233 (35.2) 236 (75.9) 75 (24.1) 102 (64.6) 23 (18.4) 218 (81.3) 50 (18.7)
Gender (male) 175 (30.5) 100 (37.3) 59 (18.2) 25 (30.1) 62 (83.8) 12 (16.2) 54 (17.5) 17 (29.8)
Acute admission 231 (54.1) 196 (45.9) 79 (59.4) 54 (40.6) 91 (78.4) 25 (21.6) 68 (68.7) 31 (31.3)
Alcohol, 4 or more units/
daily
24 (54.5) 20 (45.5) 16 (76.2) 5 (23.8) 5 (83.3) 1 (16.7) 16 (80.0) 4 (20.0)
Cognitive impairment 141 (50.0) 141 (50.0) 90 (66.7) 45 (33.3) 17 (58.6) 12 (41.4) 84 (68.3) 39 (31.7)
ADL problems 172 (53.8) 148 (46.2) 86 (73.5) 31 (26.5) 42 (72.4) 16 (27.6) 80 (78.4) 22 (21.6)
History of delirium 34 (56.7) 26 (43.3) 11 (68.8) 5 (31.2) 10 (66.7) 5 (33.3) 10 (71.4) 4 (28.6)
Vision/hearing problems 147 (56.8) 112 (43.2) 52 (67.5) 25 (32.5) 63 (80.8) 15 (19.2) 43 (75.4) 14 (24.6)
Medication 5 or more 229 (60.4) 150 (39.6) 102 (74.5) 35 (25.5) 71 (77.2) 21 (22.8) 90 (82.6) 19 (17.4)
Comorbidity, 2 or more 
illnesses
132 (55.5) 106 (44.5) 48 (60.8) 31 (39.2) 46 (75.4) 15 (24.6) 47 (65.3) 25 (34.7)
Table 2  Development of the delirium risk assessment score (DRAS) to predict delirium in the development cohort (N = 842), univariate and 
multivariate analyses
Risk factors Univariate Multivariate Final DRAS
OR 95% CI P OR 95% CI P Points
Acute admission 4.04 2.94–5.55  < 0.001 2.99 2.12–4.22  < 0.001 3
Alcohol, 4 or more units/day 1.85 1.00–3.41 0.046 2.7 1.34–5.45 0.01 3
Cognitive impairment 3.41 2.51–4.63  < 0.001 2.4 1.72–3.36  < 0.001 3
ADL/mobility problems 2.88 2.14–3.89  < 0.001 1.91 1.36–2.68  < 0.001 2
Age, 75 years or older 2.27 1.52–3.39  < 0.001 1.46 0.93–2.28 0.14 1
Vision/hearing problems 2.09 1.54–2.83  < 0.001 1.34 0.95–1.90 0.10 1
Medication, 5 or more prescriptions 1.92 1.43–2.57  < 0.001 1.35 0.97–1.88 0.10 1
History of delirium 1.71 1.01–2.92 0.045 1.54 0.84–2.83 0.16 1
Comorbidity, 2 or more illnesses 2.19 1.60–1.49  < 0.001 Excluded 0.83 Excluded
Gender (male) 1.36 1.00–1.84 0.051 Excluded Excluded
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score the more patients developed delirium, at a score of 11 
it was 82.4% and with a score of 12 to 14 it was 100%. The 
AUC of the validation cohorts ranges from 0.75 to 0.87, the 
sensitivity 0.67 to 0.89 and specificity from 0.60 to 0.72 
(Table 3). 0.69
The comparison of the DRAS with other screening instru-
ments for delirium (Kalisvaart, Dutch VMS and Inouye) 
revealed a somewhat higher AUC for the DRAS but overlap-
ping confidence intervals: DRAS 0.75 (95% CI 0.69–0.82), 
Kalisvaart AUC 0.74 (95% CI 0.67–0.81), VMS AUC 0.69 
(95% CI 0.62–0.77), Inouye AUC 0.66 (95% CI 0.59–0.74) 
(Fig. 1). The sensitivity for the DRAS was 0.67, Kalisvaart 
0.78, VMS 0.75 and Inouye 0.97. The specificity for the 
DRAS was 0.72, Kalisvaart 0.66, VMS 0.58 and Inouye 0.14 
(Table 3).
Discussion
The delirium risk assessment score (DRAS), based solely 
on information that is most times readily available, or easy 
to obtain and easy to interpret by nurses and doctors, has 
been shown to be satisfactorily accurate in the assessment 
of risk of delirium. Despite evidence of a high risk of devel-
oping delirium in all kinds of patient populations, reliable 
studies on risk factors and prediction of delirium by nurses 
and doctors are rare. In a review article of Lindroth et al. 
(2017), 23 delirium prediction models for different patient 
populations were identified of which 14 were externally 
validated. Of these 14 models the overall predictive ability 
was moderate to high with an AUC ROC range from 0.52 to 
0.94 [15]. Besides these 14 studies two other studies can be 
found which are externally validated [38, 39]. Most of the 
found models used scales (MMSE, Clock drawing, Geriat-
ric Depression Scale (GDS), APACHE II) and/or laboratory 
tests, which are laborious and time-intensive and require 
training to be used in daily practice [15]. Furthermore, the 
results of cognition testing, e.g., MMSE or other patient-
reported tests done on admission, are known to have low 
reliability when the patient is in stress of the admission, or 
is severely ill, unable to respond or is being tested at busy 
emergency departments [40]. Another point made by Wood-
ford was that small cognitive screening tests for unselected 
populations may result in more false positives than true-
positive cases. And the best method of classifying cognitive 
impairment is a comprehensive clinical evaluation [41].
Methodological shortcomings of the prediction model 
studies have been reported. The assessment of the outcome 
variable delirium was largely non-systematic, only once 
daily and not in weekends or every 48 h. In the studies that 
assessed delirium more than once per day, the assessment 
was performed by routine clinical staff, decreasing consist-
ency [15]. This is a major limitation for an acute condition 
that fluctuates, may occur suddenly and is dependent on pre-
cise, objective assessment. Most studies used the confusion 
assessment method (CAM), but only a few confirmed the 
diagnoses by a geriatrician or psychiatrist.
To improve delirium prediction models, future models 
should consider using standard risk factors (predisposing 
and/or precipitating) used in daily care and should prefer-
ably be applicable for more populations. In the Netherlands, 
patients receive an admission interview administered by 
doctors and nurses when they are admitted to a hospital. In 
this admission interview most predisposing risk factors for 
delirium are established.
The DRAS is a simple delirium risk screenings instru-
ment. It showed satisfactory validity to predict delirium in 
the development cohort and three validation cohorts. Its 
AUC of 0.75 in the development cohort and 0.78 in the vali-
dation cohort lays within the range of AUCs (0.53–0.81) of 
the other delirium prediction screenings instruments found 
in the literature [15]. But the strength of the DRAS is its 
Table 3  Validity of the delirium risk assessment score (DRAS) in the development cohort, three validation cohorts and the comparison with two 
other
Asymptomatic
N AUC 95% CI P Sensitivity Specificity
Validity of the DRAS in the development cohort
 Development cohort 842 0.75 0.72 0.79  < 0.001 0.79 0.58
Validity of the DRAS in three validation cohorts
 Validation—cohort 1 408 0.75 0.69 0.81  < 0.001 0.71 0.72
 Validation—cohort 2 186 0.78 0.70 0.87  < 0.001 0.60 0.89
 Validation—cohort 3 365 0.75 0.69 0.82  < 0.001 0.67 0.74
Validity of three other delirium risk screening tools in cohort 3
 Kalisvaart screening tool 365 0.74 0.67 0.81  < 0.001 0.78 0.66
 VMS screening tool 365 0.69 0.62 0.77  < 0.001 0.75 0.58
 Inouye screening tool 365 0.66 0.59 0.74  < 0.001 0.97 0.14
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simplicity and feasibility in clinical practice: Each nurse and 
doctor can easily and quickly assess and interpret all of the 
DRAS risk items based solely on brief admission interview 
or just asking six simple questions to the patient or his/her 
relative.
The DRAS performs as accurately or somewhat better 
compared to the other screening instruments like the Kalis-
vaart screening tool [10], the Inouye screening tool [9] and 
the VMS screening tool [16]. The DRAS does not require 
elaborate testing (of which the outcome may not be reliable) 
[40, 41], laboratory results and/or training of nurses and doc-
tors. Due to this, there is no delay in starting preventive 
interventions for delirium.
The strength in this study lays also in the fact that the 
DRAS was developed in a heterogeneous patient population, 
making it possible to use the DRAS in different patient pop-
ulations. The large number of patients included underlines 
that our results are robust. Furthermore, the assessment of 
delirium in all our studies was done by a trained person on a 
daily basis using the confusion assessment method and the 
diagnosis was confirmed by a geriatrician.
The study limitations to be addressed are that the devel-
opment and validation was not externally validated. There 
was a validation done in cohort 3 which came from another 
hospital, but of this cohort data were already available from 
another study. Also, preventive interventions for delirium 
done by the geriatric liaison service in our hospital may 
have possibly influenced the incidence rate of delirium. 
This study included all eligible patients from several wards, 
a heterogeneous patient population, in a general teaching 
hospital, so the fact that the validation was limited to an 
orthopedic and surgical population may raise questions, but 
nevertheless, the results on DRAS risk assessment in the 
third validation cohort were the same or better compared to 
the other screening instruments.
Conclusion
Based on the admission interview, the delirium risk can be 
very easily evaluated by using the DRAS shortlist score of 
predisposing risk factors for delirium in older inpatients.
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